[go: up one dir, main page]

ATE532861T1 - Expressionsvektor - Google Patents

Expressionsvektor

Info

Publication number
ATE532861T1
ATE532861T1 AT04783263T AT04783263T ATE532861T1 AT E532861 T1 ATE532861 T1 AT E532861T1 AT 04783263 T AT04783263 T AT 04783263T AT 04783263 T AT04783263 T AT 04783263T AT E532861 T1 ATE532861 T1 AT E532861T1
Authority
AT
Austria
Prior art keywords
expression vector
expression
nucleic acids
host cells
desired polypeptide
Prior art date
Application number
AT04783263T
Other languages
English (en)
Inventor
Amelia Black
Original Assignee
Medarex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medarex Inc filed Critical Medarex Inc
Application granted granted Critical
Publication of ATE532861T1 publication Critical patent/ATE532861T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT04783263T 2003-09-04 2004-09-03 Expressionsvektor ATE532861T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50080303P 2003-09-04 2003-09-04
PCT/US2004/028954 WO2005024015A1 (en) 2003-09-04 2004-09-03 Expression vector

Publications (1)

Publication Number Publication Date
ATE532861T1 true ATE532861T1 (de) 2011-11-15

Family

ID=34272998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04783263T ATE532861T1 (de) 2003-09-04 2004-09-03 Expressionsvektor

Country Status (7)

Country Link
US (1) US7674618B2 (de)
EP (1) EP1660654B1 (de)
JP (1) JP4751326B2 (de)
AT (1) ATE532861T1 (de)
CA (1) CA2536807C (de)
ES (1) ES2374526T3 (de)
WO (1) WO2005024015A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007117410A2 (en) * 2006-03-31 2007-10-18 Medarex, Inc. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
HUE027165T2 (en) 2006-10-02 2016-08-29 Squibb & Sons Llc Human antibodies that bind to CXCR4 and their uses
CA2671457C (en) 2006-12-01 2017-09-26 Medarex, Inc. Human antibodies that bind cd22 and uses thereof
DK2147105T3 (da) * 2007-05-02 2013-06-03 Merial Ltd Dna-plasmider med forbedret ekspression og stabilitet
RU2456346C2 (ru) * 2007-05-02 2012-07-20 Мериал Лимитед Днк-плазмиды, обладающие повышенной экспрессией и стабильностью
EP2235198B1 (de) * 2007-12-19 2018-08-29 GlycoFi, Inc. Hefestämme für die Proteinproduktion
PL3075858T3 (pl) * 2007-12-21 2020-07-13 Novartis Ag Ssaczy wektor ekspresyjny
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
JP4525863B1 (ja) * 2009-06-05 2010-08-18 東洋紡績株式会社 高生産性細胞の樹立のための発現ベクター及び高生産性細胞
JP4547643B1 (ja) * 2009-06-05 2010-09-22 東洋紡績株式会社 クローニングに最適化された発現ベクター
JP4491808B1 (ja) * 2009-06-05 2010-06-30 東洋紡績株式会社 高発現細胞の効率的な選別に有用な薬剤選択マーカー遺伝子発現カセット
MX357100B (es) 2011-11-09 2018-06-26 Bristol Myers Squibb Co Tratamiento de neoplasias hematologicas con un anticuerpo anti-cxcr4.
AU2017263454B2 (en) * 2016-05-11 2023-02-09 Amgen Inc. Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors
MX2021006241A (es) * 2018-12-04 2021-08-11 Catalent Pharma Solutions Llc Vectores para la fabricacion de proteinas.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4876197A (en) 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
ES2084596T3 (es) 1988-12-13 1996-05-16 Harvard College Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas.
US5256568A (en) * 1990-02-12 1993-10-26 Regeneron Phamaceuticals, Inc. Vectors and transformed most cells for recombinant protein production with reduced expression of selectable markers
WO1992001800A1 (en) 1990-07-20 1992-02-06 Chiron Corporation Method for integrative transformation of yeast using dispersed repetitive elements
CA2149326C (en) 1992-11-13 2007-04-17 Mitchell E. Reff Fully impaired consensus kozak sequences for mammalian expression
US5648267A (en) * 1992-11-13 1997-07-15 Idec Pharmaceuticals Corporation Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
US5627033A (en) * 1995-03-28 1997-05-06 Research & Diagnostics Systems, Inc. Mammalian expression vectors
US5928941A (en) * 1996-10-07 1999-07-27 President And Fellows Of Harvard College Repressor kruppel-like factor
ES2242997T3 (es) * 1997-03-14 2005-11-16 Biogen Idec Inc. Metodo para integrar genes en sitios especificos en celulas de mamifero por medio de recombinacion homologa y vectores para realizar el mismo.
US6444421B1 (en) * 1997-11-19 2002-09-03 The United States Of America As Represented By The Department Of Health And Human Services Methods for detecting intermolecular interactions in vivo and in vitro
CA2389633A1 (en) 1999-11-01 2001-05-10 Chiron Corporation Expression vectors, transfection systems, and method of use thereof
US20040029229A1 (en) * 2002-05-20 2004-02-12 Reeves Philip J. High level protein expression system

Also Published As

Publication number Publication date
US7674618B2 (en) 2010-03-09
EP1660654B1 (de) 2011-11-09
CA2536807C (en) 2010-07-13
JP2007503837A (ja) 2007-03-01
JP4751326B2 (ja) 2011-08-17
ES2374526T3 (es) 2012-02-17
EP1660654A1 (de) 2006-05-31
CA2536807A1 (en) 2005-03-17
WO2005024015A1 (en) 2005-03-17
EP1660654A4 (de) 2007-08-22
US20050153394A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
PH12020550771A1 (en) Gene editing using a modified closed-ended dna (cedna)
MX2020004578A (es) Composiciones de casz y metodos de uso.
CY1121132T1 (el) ΠΛΗΡΩΣ-ΑΝΘΡΩΠΙΝΑ ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ANTI-vap-1
EP4431607A3 (de) Hochdurchsatz-präzisionsgenomeditierung
ATE532861T1 (de) Expressionsvektor
WO2003080807A3 (en) Compositions and methods for suppressing eukaryotic gene expression
WO2004099370A3 (en) NOVEL BACILLUS mHKcel CELLULASE
DK1928901T3 (da) Polypeptider, der har beta-glucosidaseaktivitet og polynukleotider, der koder for samme
DE60215534D1 (de) Antimikrobielle polypeptide aus pseudoplectania nigrella
WO2020219682A3 (en) Gene knock-outs to improve t cell function
WO2004101760A3 (en) Novel lipolytic enzyme elip
DK1685247T3 (da) Vektorer til retningsbestemt kloning
DK1675956T3 (da) Minimal DNA-sekvens, der virksom som chromatinisolator, og dennes anvendelse til proteinekspression
WO2016130628A8 (en) Griffithsin mutants
WO2007051063A3 (en) Gpcr expressing cell lines and antibodies
ZA200610470B (en) Novel sequence for improving expression of nucleic acid
ATE549408T1 (de) Lineare vektoren, wirtszellen und klonverfahren
MX2008002485A (es) Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que los codifican.
WO2007134325A3 (en) Methods and compositions for protein production using adenoviral vectors
SG169325A1 (en) Promoters for expression in modified vaccinia virus ankara
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
TW200700076A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
TW200621284A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
DK2066790T3 (da) Galactosyltransferase
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid